Company News
Zydus Lifesciences 31st AGM Transcript FY2026
Zydus Lifesciences held its 31st AGM, reporting 17% revenue growth to ₹27,148 crore and an EBITDA margin of 31.2% for FY2026.
The Board approved a ₹1,100 crore share buyback and declared a 100% divide
